The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Category Archives: This Week in the Twitterverse

Weekend Reading: This Week in the Twitterverse

Catch up on the week’s biotech developments and news from our Twitter stream @crossborderbio:

Weekend Reading: This Week in the Twitterverse

Catch up on the week’s biotech developments and news from our Twitter stream @crossborderbio:

Weekend Reading: This Week in the Twitterverse

Social media, publication quality, Canadian VC policy and exhaustion (mine and patents’) make for a light dose of interesting reading this weekend:

  • Friday Science Review: stagnant technologies in Africa, congenital blindness in children and chronic pain in the crosshairs… http://ow.ly/1auHag
  • Social Media Reshaping Healthcare: Some cool data on the use of Twitter as a Public Health Surveillance Tool http://ow.ly/1atGkw
    • Also… Deloitte’s report on social networks for lifesciences: Valuable communication tool or just tweets and word games http://ow.ly/3orb9
    • And/but…  Pharma skeptical of social media http://bit.ly/ha2Nn0
  • Huge. Watch what comes from this… RT @FierceBiotech: NIH steps in to propel research projects into the clinic. http://bit.ly/hWWc0m
  • Lilly Suspends Phase III Trial in Metastatic Melanoma http://bit.ly/gVcuxY (RT @PharmProEditor)
  • This may be a long road for DoD – I worked on a related project in ’91! RT @FierceBiotech: DoD awards $1.3M grant to develop artificial blood. http://bit.ly/dGfZp1
  • MaRS CEO Ilse Treurnicht notes that China is now 2nd in publication of biomedical research articles globally, recently surpassed Japan, UK, Germany…Canada…  Canadian expat Taylor Raborn asks: is their average publication of the same quality as those from Japan or Germany? Well, “quality” is hard to measure, of course. By citation rate, the answer is no. Nature has very cool data showing publication volume and citation rate http://bit.ly/gydYLk
  • Venture Capital (VC) for Canada Campaign: B.C shows exemplary leadership, will others follow?http://eqent.me/fgl7Je RT @CVCACanada
  • 4-4 split leaves 9th Cir decision intact RT @patentlyo: Supreme Court Does not Decide Costco v. Omega Int’l Exhaustion Case http://bit.ly/f1z3xM

This Week in the Twitterverse – Weekend Reading

Here’s your dose of weekly biotech news, all wrapped up in one weekend-friendly package:

This Week in the Twitterverse: Weekend Reading

Here’s your dose of weekly biotech news, all wrapped up in one weekend-friendly package thanks to our Twitter stream:

  • RT @ArsenicMicrobes: We come in peace – Funny! But agree with @matthewherper on this one: not an alien http://bit.ly/ebEPxe
  • Never too early for biotechs and VCs to understand and plan for payer-focused endpoints http://bit.ly/fDEsbL via @InVivoBlogChris
  • My short presentation from the CHLA holiday event on Canadian Biotech and Pharma Licensing Trends http://ow.ly/1ahqq1
  • Canadian Biotech and Healthcare Licensing Trends in 2010 http://ow.ly/1ahqq1
  • Ogilvy Renault ‘s Rick Sutin and BIOTECanada’s Peter Brenders on bringing flow-thru shares to the biotech sector in Canada http://bit.ly/fOBMSj
  • What’s your best price? Amgen’s Nplate latest example of drug winning NICE backing after offering rebate to UK’s NHS, from @reutersBenHir:
  • BC biotech company bets the farm on GM non-browning apples http://bit.ly/g5EPQ0
  • Made here, bought elsewhere… RT @robannan: Innovation moves south – government watches it go. New blog post.http://bit.ly/gycbZT
  • Merck Prez Ken Frazier to become CEO in Jan. http://yhoo.it/hUppEh. Background from Fierce Biotech at http://bit.ly/eYFTZB
  • One of the outcomes from H1N1/swine flu pandemic… RT @CBCHealth: Ont. to give new powers to chief medical officerhttp://bit.ly/i7DVAg
  • RT @jonmrich: Forget Harry Potter. Call of Duty: Black Ops: Sold $650 million in 5 days. Breaks EVERY entertainment opening. Amazing.
  • Allon (TSX:NPC) lands $625k grant from MJFF for pre-clinical work on davunetide as a treatment for Parkinson’shttp://bit.ly/eLVeey
  • NB Premier says he’s open to idea of regional fund, proposes $50m for Atlantic biotech/cleantech/IT http://bit.ly/ggTkwN
  • Medical genetics and personalized medicine issue of Stanford Medhttp://bit.ly/eRNDKZ

This Week in the Twitterverse

Here’s your dose of weekly biotech news, all wrapped up in one weekend-friendly package thanks to our Twitter stream @crossborderbio:

 

This Week in the Twitterverse

Here’s your dose of weekly biotech news, all wrapped up in one weekend-friendly package thanks to our Twitter stream @crossborderbio:

 

This Week in the Twitterverse

Here’s your dose of weekly biotech news, all wrapped up in one weekend-friendly package thanks to our Twitter stream @crossborderbio:

This Week in the Twitterverse

Some weekend reading from our Twitter stream @crossborderbio:

This Week in the Twitterverse

If you’re not following our Twitter stream @crossborderbio, here’s what you missed this week:

This Week in the Twitterverse

Some weekend reading from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

Lots of great weekend reading from our Twitter stream on @crossborderbio, including news and commentary on the latest in personalized medicine and the Canadian VC landscape:

 

This Week in the Twitterverse

Here’s some weekend reading from our Twitter stream on @crossborderbio …

  • Friday Science Review is back, thx to Mark Curtis! Today’s cool Canadian science = tomorrow’s cool startups… http://ow.ly/19f2te1
  • DTC genetics link in last tweet is from @CMAJ_News – also contrasts Class III regulation of companion diagnostics. I.e. DTC is non-clinical?
  • MT @genomicslawyer: …Health Canada is taking a “far more relaxed approach” than U.S. regulators to DTC genetics http://bit.ly/bX3Il7
  • RT @JohnCFierce: Covance is buying 3 R&D facilities from sanofi and inked a 10-yr research contract worth up to $2.2B http://reut.rs/dBbQ7F
  • RT @MSBiV: Leap Medical completes second tranche of financing http://bit.ly/dl7KbL a @McGillU spin-off and @MSBiV investee
  • Planning to! RT @robannan: I’m going – anyone else? RT @JVPLS @sciencepolicy Canadian Science Policy Conf Mtl Oct.20-22 http://ow.ly/2KpWG
  • Biovail, Valeant shareholders vote to approve merger, expected to close tomorrow. http://bit.ly/aAstb0
  • RT @MaRSDD: Blog – Got a management challenge? Win a ticket to see Malcolm Gladwell! … http://bit.ly/cdQkDv
  • RT @genomicslawyer: BGI as one of China’s multiple “moon shots”, as told by Thomas Friedman of NYT: http://nyti.ms/aJlNvY H/T @phylogenomics
  • Happy Bday! RT @IlseTreurnicht: Birthday cake @MaRSDD: 5 years since opening of the MaRS Centre today…
  • Healthcare giving down in the U.S. and up in Canada (2008 vs 2009, tho 2009 in Canada just = recovery to 2006 levels) http://bit.ly/aaENDU

This Week in the Twitterverse

Lots of great weekend reading from our Twitter stream on @crossborderbio, including a plane that flies like a bird, a $450 million licensing deal and links to several worthwhile upcoming events:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

Even though posts have dropped off between the long weekend last week and some business travel, I’ve been keeping Twitter up to date and will resume with a two-week deal review on Monday. In the meantime, here’s some reading to catch up on:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

As you may have surmised (from my out-of-office email or from my attempts to get the attention of Delta’s customer service tweeps) I was out of town this week. Still, here’s some weekend reading for you from our Twitter stream @crossborderbio:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

  • RT @IBMResearch: Roche and IBM Collaborate to Develop Nanopore-Based DNA Sequencing Technology – http://cot.ag/9vbj8l 
  • RT @CBCHealth: Chalk River reactor to restart in July: AECL http://bit.ly/d66r72 
  • RT @ogilvyrenault: Ogilvy Renault’s Rick Sutin quoted in Financial Post article on TSX/TSXV’s strength in cleantech http://bit.ly/cFAXr2 
  • RT @markrmcqueen @theC100 Another C100 financing: Altos Ventures backs Toronto/SF-based Kontagent for social analytics http://fb.me/zG06wkZQ
  • SV Life Sciences closes Fund V. Aimed for $400m, got $523m. http://bit.ly/9SSCPv Congrats! Come invest some of that extra $ in Canada! 
  • RT @FierceBiotech: Developers lobby for new federal R&D incentives for rare diseases. http://bit.ly/bXxgeW 
  • via @genomicslawyer Prometheus remanded to Federal Circuit post-Bilski http://bit.ly/cuAGFH 
  • RT @davidcrow @bwat: The VC Shakeout – Harvard Business Review: http://bit.ly/bRmkvw 
  • CTI makes $3.2m follow-on investment in Zymeworks (Vancouver antibody therapeutics co) http://bit.ly/aQWhy5 
  • Immunovaccine (TSXV $IMV) and Oncothyreon ($ONTY) developing a potential therapeutic cancer vaccine. $ not disclosed. http://bit.ly/avjP69 
  • Where head on = minimalist tiptoeing? RT @genomicslawyer: GLR Post: Bilski and Biotech: Business As Usual, For Now: http://bit.ly/9isN5O
  • RT @AHCJ_Pia: Healthcare.gov coming July 1 http://bit.ly/b65NcV 
  • Aeterna Zentaris ($AEZS) & Almac working on Cancer Therapy+Companion Diagnostic for LHRH expression. $ not disclosed. http://bit.ly/bnCdXa
  • Notable awards: Fate Therapeutics wins Red Herring http://bit.ly/9vU9dp QIAGEN-DxS wins Medscience Txn of the Year http://bit.ly/9ZiUaP
  • RT @ogilvyrenault: OMERS and Dutch pension fund, ABP, Establish €200 Million Fund for Canadian and Dutch Start-Ups http://bit.ly/98EDOe
  • New Post: Key Quotes from the U.S. Supreme Court’s Decision in Bilski Shows No Current Impact on Biotech http://ow.ly/17UTQB 
  • Solving today’s SCOTUS issues in <140: The President can appoint an oversight board to patent methods of gun use. Ta da! 
  • Everybody relax. Sarbanes-Oxley Act “remains ‘fully operative as a law’ with [the PCAOB] tenure restrictions excised” http://bit.ly/aOwHnG 
  • Tesla increases # of IPO shares by 20%. http://bit.ly/cgsKy4 from Bloomberg via @cleanlantern
  • @lindaavey still reading, but even if Bilski was seismological I think it’s more “tremor” than “quake”.
  • More Bilski:”all members of the Court agree that the patent application at issue here falls outside of §101 b/c it claims an abstract idea.”
  • More Bilski “while §273 appears to leave open the possibility of some business method patents, it does not suggest broad patentability…”
  • From Bilski: “The machine-or-transformation test is not the sole test for deciding whether an invention is a patent-eligible ‘process.’”
  • Bilski process is unpatentable, but SC disapproves “an exclusive machine-ortransformation test”! Link to full pdf http://bit.ly/aKIjCx
  • RT @SCOTUSblog: Real-time SCOTUS: Bilski v. Kappos, affirmed, Justice Kennedy writes for the majority.
  • RT @FierceBiotech: AstraZeneca is opening up ~500,000 of its chemical compounds to the Medicines for Malaria Venture. http://bit.ly/bN8Nc4

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

  • RT @PharmProEditor: Intellipharmaceutics plans Effexor generic http://bit.ly/aKNOMp
  • RT @CVCACanada: VC deals: Montreal based Enerkem announces funding from Alberta Energy http://bit.ly/aznzgC
  • BELLUS Health ends NC-503 diabetes development program following Phase II results http://viigo.im/3q8b
  • Aeterna Zentaris Receives Orphan-Drug Designation from the FDA for AEZS-108 in Ovarian Cancer http://viigo.im/3q7M 
  • RT @tdmckee: A paper from my lab is online in Nature, and today’s Toronto Star! http://bit.ly/9lwRSa << Awesome! Congrats!
  • RT @nvca LP Panel: there is optimism for venture equal to late 1990s
  • SickKids is building a $400 million, 21-storey, 750,000 square foot Research & Learning Tower at Bay & Elm http://viigo.im/3psl
  • Sanofi-aventis Canada announces 70 jobs cut by July, criticizes Canadian IP and access to medicines policies. http://viigo.im/3prD
  • RT @FierceBiotech: Live from BIO 2010: Hamburg discusses advancing regulatory science. http://is.gd/bVgWp
  • RT @jensmccabe USAToday joins hospital stats game – see hospitals death/readmission rates for heart attack, heart failure, pneumonia at health.usatoday.com 
  • RT @SternIR Burrill: 09 best yr ever for biotech capital raise – just when Burrill etal were declaring biotech dead of capital starvation. #bio2010
  • BioMS is changing its name to MedWell Capital and hiring ex-Desjardins banker Nitin Kaushal as EVP/MD http://bit.ly/a8uNNp
  • RT @CVCACanada: From out of the ashes – blog by @davidcrow on Canadian VC rebirth http://bit.ly/9daSeQ via @startupnorth 
  • E&Y: 7 of 9 deals over $1B involved non-US buyers #bio2010
  • New Post: Biotech Trends Update: Non-Dilutive Financing and Fundraising by Partnering with Nonprofits http://ow.ly/17fTXj
  • RT @FierceBiotech: E&Y: In 2009, 14 percent of biotech companies closed their doors. Far less than the 25% to 33% expected..
  • Report on the Non-Dilutive Financing and Fundraising by Partnering with Nonprofits panel at #BIO2010 http://ow.ly/1GuqA
  • RT @curlygh RT @BIOConvention: Our nation faces growing racial disconnect between those that seek care & those that provide it. -Surgeon Gen
  • Latest data on biotech jobs and state initiatives from BIO and Battelle session at BIO 2010 http://ow.ly/17fGuN
  • Note to #bio2010 peeps from warmer climes: not too late to mutate. Mammoth hemoglobin released O2 equally at all temps! http://bit.ly/c36ggv

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio:

  • Canadian Foundation for Innovation’s Leaders Opportunity Fund supports 10 McGill researchers http://bit.ly/aRuStd for $1.7M
  • Medicago $MDG headed for the TSX big board (from the Venture exchange) http://bit.ly/cY68Dl Congratulations!
  • Genome Canada discloses planned allocation of $75m 2010 budget http://bit.ly/ccANNC
  • Canada’s drug spend hit $30b in 2009 (85% prescription,15% OTC), but rate of increase (5.1%) was the lowest in a decade http://bit.ly/blfWbR
  • Ontario is contributing $11.5m to Dr. Mick Bhatia’s lab at McMaster University for stem cell-based therapies http://bit.ly/a6dodA
  • Excellent post at the Genomics Law Report on the complexities of informed consent for genomic studies: http://bit.ly/96DAboh
  • Finishing the job of polio eradication worldwide is an ethical obligation! http://bit.ly/9BYTeR
  • cleantech with $ > biotech w/o RT @JohnCFierce: Alimera slashes its IPO price, Codexis delivers at low end of range… http://bit.ly/9z2m2q
  • Two very different and fun approaches to forward-looking information disclaimers noted in this post. Why be boring? http://bit.ly/96T5PO
  • Canada’s Gemin X picked up a $16 million Series D. http://bit.ly/9GgZpN
  • Updated Pharma and Healthcare Social Media Wiki @ http://bit.ly/aCDtoI Great tool to find companies, patient communities, industry observers
  • Genomics Law Report gets an early start on DNA Day hosting Blawg Review http://bit.ly/aPDmk1 & Scientia Pro Publica http://bit.ly/dmpOSs 
  • WSJ VC Blog looks at share of VC investment by industry since 2001 – decline of IT is the primary trend http://bit.ly/cSBNGr
  • Biomarker breakthrough highlights potential of adaptive trials. http://is.gd/bzuqb 
  • Bioniche Receives $750,000 from FedDev for Fermentation Scale-Up for New Vaccine Manufacturing Centre
  • Experts share tips for developing drugs using a virtual model. http://is.gd/bzlZA << good clinical trial CRO plan advice 
  • Vineland Research and Innovation Centre collaborates with Raytheon on radiowave prototype to protect crops from frost http://bit.ly/9JRfMr 
  • Ten Types of Hair on Early-Stage Deals http://bit.ly/9M8sos
Follow

Get every new post delivered to your Inbox.

Join 126 other followers